Valtoco (diazepam nasal spray) is an FDA-approved medication for the treatment of seizure clusters in individuals aged two and older who can be safely managed with a rectal dosage form of diazepam [1][2]. It is designed for rapid absorption through the nasal mucosa, offering a more easily administered alternative to rectal administration in certain situations [3][4].
How does Valtoco work for seizure clusters?
Valtoco delivers diazepam, a benzodiazepine, directly into the bloodstream via the nasal passages. This route of administration allows for quicker absorption compared to oral medications, which is crucial for effectively managing acute seizure activity. Once absorbed, diazepam acts on the central nervous system by enhancing the effects of gamma-aminobutyric acid (GABA), an inhibitory neurotransmitter. This increased inhibition helps to stop or reduce the excessive electrical activity in the brain that causes seizures [4][5].
What are the benefits of using Valtoco for seizure management?
The primary benefit of Valtoco is its ease of administration, particularly for caregivers who may find nasal delivery more straightforward and less intrusive than rectal administration, especially in public settings or when dealing with a distressed patient. Its rapid absorption also means it can start working more quickly to stop prolonged seizures, potentially reducing the risk of status epilepticus [3][4]. This rapid action and ease of use aim to provide a more reliable and less stressful option for managing breakthrough seizures [3].
What are the potential risks and side effects of Valtoco?
Like all benzodiazepines, Valtoco carries risks and potential side effects. Common side effects include drowsiness, dizziness, and nasal discomfort. More serious risks include respiratory depression, central nervous system depression, and potential for misuse or dependence. It is important for caregivers to be trained on its proper use and to understand when to seek emergency medical attention [6][7]. Valtoco is intended for short-term use to manage seizure clusters, not as a daily maintenance medication [1].
Are there other nasal spray seizure medications available?
Currently, Valtoco is the only FDA-approved nasal spray formulation of diazepam for the treatment of seizure clusters. However, other seizure medications are available in different formulations, including rectal gels and oral tablets. The choice of medication and administration method often depends on individual patient needs, caregiver preference, and physician recommendation [4][8].
When does the patent for Valtoco expire?
Information regarding specific patent expiry dates for Valtoco is available through resources like DrugPatentWatch.com [9]. These patents typically cover the drug substance, formulation, and methods of use, influencing the timeline for potential generic competition [10]. Understanding patent landscapes is crucial for assessing future market availability and pricing of medications.
*
**Sources:
1. https://www.valtoco.com/
2. https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/211348s000lbl.pdf
3. https://www.multibriefs.com/content/valtoco-a-nasal-diazepam-for-acute-repetitive-seizures/
4. https://www.neurologyadvisor.com/home/topics/epilepsy/seizure-clusters/valtoco-diazepam-nasal-spray-for-seizure-clusters/
5. https://www.drugs.com/diazepam.html
6. https://www.webmd.com/drugs/2/drug-143165/diazepam-nasal-nasal-spray/details
7. https://www.goodrx.com/valtoco
8. https://www.epilepsy.com/treatments/drugs
9. https://drugpatentwatch.com/
10. https://www.law.cornell.edu/wex/patent